A number of investment brokers have recently updated their price targets on shares of Biotie Therapies Corp. (NASDAQ:BITI). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/21/2016 – Biotie Therapies Corp. was downgraded to “sector perform” by analysts at RBC Capital.

07/07/2015 – Roth Capital began new coverage on Biotie Therapies Corp. giving the company a “buy” rating. They now have a USD 26 price target on the stock.

07/06/2015 – JMP Securities began new coverage on Biotie Therapies Corp. giving the company a “outperform” rating. They now have a USD 32 price target on the stock.

07/06/2015 – Stifel Nicolaus began new coverage on Biotie Therapies Corp. giving the company a “buy” rating. They now have a USD 30 price target on the stock.

The share price of Biotie Therapies Corp. (NASDAQ:BITI) was up +0.00% during the last day of trading, with a day high of 27.02. 5697 shares were traded during the last session.

The stock’s 50 day moving average is 26.37 and its 200 day moving average is 20.45. The stock’s market capitalization is 327.71M. Biotie Therapies Corp. has a 52-week low of 12.43 and a 52-week high of 27.96.

View other investors thoughts on Biotie Therapies Corp. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.